In: PATENT NEWS
Lincoln Pharma bags patent for anti-malarial drug Dalal Street Investment Journal Govt awards patent to Lincoln Pharma BSI bureau (press release) Lincoln Pharmaceuticals awarded patent for Antimalarial Drug United News of India Full coverage
In: PATENT NEWS
ITC Becomes Appealing Venue for Patent Suits in Light of Supreme Court Decision Lexology Full coverage
In: PATENT NEWS
Law360, San Francisco (December 18, 2017, 8:31 PM EST) — Sandoz Inc. urged a California federal judge Monday to find it hadn’t infringed on Amgen Inc.’s patent related to the biologic Neulasta, which treats chemotherapy side effects, because the recipe for Sandoz’s biosimilar doesn’t involve the …
In: PATENT NEWS
Law360, San Jose (December 18, 2017, 7:42 PM EST) — Citing the TC Heartland precedent, Mercedes-Benz USA LLC told a Florida federal court Monday that a Texas company’s patent lawsuit over Mercedes’ use of QR codes was filed in the wrong state and should be dismissed or moved to Georgia, …
In: PATENT NEWS
Law360, New York (December 18, 2017, 7:30 PM EST) — Cook Medical LLC won a rare rehearing at the Patent Trial and Appeal Board on Monday, a decision that will allow it to argue that all parts of a Boston Scientific Scimed Inc. patent for a medical device used to... Continue reading
In: PATENT NEWS
Fed. Circ. Upholds Genzyme’s Win In Stem Cell Patent Case Law360 Full coverage
In: PATENT NEWS
$10M Pepcid Patent Verdict Nixed As Judge Reverses Herself Law360 Full coverage
In: PATENT NEWS
Law360, New York (December 18, 2017, 7:02 PM EST) — Perrigo Co. has not infringed various aspects of a Boston hospital’s now-expired patent on the Pepcid Complete antacid, a Massachusetts federal judge said Friday, reversing the findings in three of her previous judgments and negating a $10.2 …
In: PATENT NEWS
Law360, New York (December 18, 2017, 7:04 PM EST) — The Federal Circuit on Monday affirmed a Delaware federal judge’s finding in a bench trial that a Genzyme Corp. patent on harvesting stem cells is valid, leaving in place a ruling that barred generic versions of the cancer drug Mobozil... Continue reading
In: PATENT NEWS
Law360, New York (December 18, 2017, 6:37 PM EST) — The Federal Circuit on Monday affirmed a Patent Trial and Appeal Board decision upholding the validity of a wireless communications patent that was challenged by HTC and ZTE, adding to a recent string of victories for an Acacia Research …
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION